Vascular endothelial growth factor induces CXCL1 chemokine release via JNK and PI-3K-dependent pathways in human lung carcinoma epithelial cells

International Journal of Molecular Sciences

Volumn 14, Issue 5, 2013, Pages 10090-10106

  Lo, Huey Ming ^a,b   Shieh, Jiunn Min ^c   Chen, Chih Li ^a   Tsou, Chih Jen ^a   Wu, Wen Bin ^a  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^c CHI MEI MEDICAL CENTER   (Taiwan)

Author keywords

A549; Chemokine; CXCL1; GRO alpha; Signaling; VEGF

Indexed keywords

CXCL1 CHEMOKINE; DEXAMETHASONE; MESSENGER RNA; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; TRANSFORMING GROWTH FACTOR BETA; VASCULOTROPIN; VASCULOTROPIN A; VEGFA PROTEIN, HUMAN;

ARTICLE; CANCER CELL; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; MONOCYTE; TRANSCRIPTION REGULATION; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; LUNG; LUNG TUMOR; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION; TUMOR CELL LINE;

CELL LINE, TUMOR; CHEMOKINE CXCL1; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG; LUNG NEOPLASMS; MAP KINASE SIGNALING SYSTEM; MONOCYTES; PHOSPHATIDYLINOSITOL 3-KINASES; SIGNAL TRANSDUCTION; TRANSCRIPTIONAL ACTIVATION; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84877809487     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms140510090     Document Type: Article

References (43)

1. Charo, I.F.; Ransohoff, R.M. The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 2006, 354, 610-621.
2. Baggiolini, M. Chemokines in pathology and medicine. J. Intern. Med. 2001, 250, 91-104.
3. Nannuru, K.C.; Singh, S.; Singh, R.K. Chemokines and Metastasis. In The Tumor Microenvironment; Bagley, R.G., Ed.; Springer: New York, NY, USA, 2010; pp. 601-631.
4. Scapini, P.; Morini, M.; Tecchio, C.; Minghelli, S.; di Carlo, E.; Tanghetti, E.; Albini, A.; Lowell, C.; Berton, G.; Noonan, D.M.; Cassatella, M.A. CXCL1/macrophage inflammatory protein-2-induced angiogenesis in vivo is mediated by neutrophil-derived vascular endothelial growth factor-A. J. Immunol. 2004, 172, 5034-5040.
5. Holmes, K.; Roberts, O.L.; Thomas, A.M.; Cross, M.J. Vascular endothelial growth factor receptor-2: Structure, function, intracellular signalling and therapeutic inhibition. Cell. Signal. 2007, 19, 2003-2012.
6. Geretti, E.; Shimizu, A.; Klagsbrun, M. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis 2008, 11, 31-39.
7. Hutchings, H.; Ortega, N.; Plouët, J. Extracellular matrix-bound vascular endothelial growth factor promotes endothelial cell adhesion, migration, and survival through integrin ligation. FASEB J. 2003, 17, 1520-1522.
8. Liu, W.; Xu, J.; Wang, M.; Wang, Q.; Bi, Y.; Han, M. Tumor-derived vascular endothelial growth factor (VEGF)-a facilitates tumor metastasis through the VEGF-VEGFR1 signaling pathway. Int. J. Oncol. 2011, 39, 1213-1220.
9. Zhan, P.; Wang, J.; Lv, X.-J.; Wang, Q.; Qiu, L.-X.; Lin, X.-Q.; Yu, L.-K.; Song, Y. Prognostic value of vascular endothelial growth factor expression in patients with lung cancer: A systematic review with meta-analysis. J. Thorac. Oncol. 2009, 4, 1094-1103.
10. Gorski, D.H.; Beckett, M.A.; Jaskowiak, N.T.; Calvin, D.P.; Mauceri, H.J.; Salloum, R.M.; Seetharam, S.; Koons, A.; Hari, D.M.; Kufe, D.W.; et al. Blockage of the vascular endothelial growth factor stress response increases the antitumor effects of ionizing radiation. Cancer Res. 1999, 59, 3374-3378.
11. Becker, S.; Quay, J.; Koren, H.S.; Haskill, J.S. Constitutive and stimulated MCP-1, GRO alpha, beta, and gamma expression in human airway epithelium and bronchoalveolar macrophages. Am. J. Physiol. 1994, 266, L278-L286.
12. Huang, M.; Wang, J.; Lee, P.; Sharma, S.; Mao, J.T.; Meissner, H.; Uyemura, K.; Modlin, R.; Wollman, J.; Dubinett, S.M. Human non-small cell lung cancer cells express a type 2 cytokine pattern. Cancer Res. 1995, 55, 3847-3853.
13. Arenberg, D.A.; Keane, M.P.; DiGiovine, B.; Kunkel, S.L.; Morris, S.B.; Xue, Y.Y.; Burdick, M.D.; Glass, M.C.; Iannettoni, M.D.; Strieter, R.M. Epithelial-neutrophil activating peptide (ENA-78) is an important angiogenic factor in non-small cell lung cancer. J. Clin. Investig. 1998, 102, 465-472.
14. Numasaki, M.; Watanabe, M.; Suzuki, T.; Takahashi, H.; Nakamura, A.; McAllister, F.; Hishinuma, T.; Goto, J.; Lotze, M.T.; Kolls, J.K.; et al. IL-17 enhances the net angiogenic activity and in vivo growth of human non-small cell lung cancer in SCID mice through promoting CXCR-2-dependent angiogenesis. J. Immunol. 2005, 175, 6177-6189.
15. Caunt, M.; Hu, L.; Tang, T.; Brooks, P.C.; Ibrahim, S.; Karpatkin, S. Growth-regulated oncogene is pivotal in thrombin-induced angiogenesis. Cancer Res. 2006, 66, 4125-4132.
16. Alexander, S.P.; Mathie, A.; Peters, J.A. Guide to receptors and channels (GRAC). Br. J. Pharmacol. 2011, 164, S1-S2.
17. Blobe, G.C.; Schiemann, W.P.; Lodish, H.F. Role of transforming growth factor β in human disease. N. Engl. J. Med. 2000, 342, 1350-1358.
18. De Caestecker, M.P.; Piek, E.; Roberts, A.B. Role of transforming growth factor-β signaling in cancer. J. Natl. Cancer Inst. 2000, 92, 1388-1402.
19. Jeon, H.-S.; Jen, J. TGF-[beta] Signaling and the role of inhibitory smads in non-small cell lung cancer. J. Thorac. Oncol. 2010, 5, 417-419.
20. Shull, M.M.; Ormsby, I.; Kier, A.B.; Pawlowski, S.; Diebold, R.J.; Yin, M.; Allen, R.; Sidman, C.; Proetzel, G.; Calvin, D.; et al. Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359, 693-699.
21. Markowitz, S.D.; Roberts, A.B. Tumor suppressor activity of the TGF-beta pathway in human cancers. Cytokine Growth Factor Rev. 1996, 7, 93-102.
22. Roberts, A.B.; Wakefield, L.M. The two faces of transforming growth factor beta in carcinogenesis. Proc. Natl. Acad. Sci. USA 2003, 100, 8621-8623.
23. Kelly, R.J.; Morris, J.C. Transforming growth factor-beta: A target for cancer therapy. J. Immunotoxicol. 2010, 7, 15-26.
24. Wislez, M.; Fujimoto, N.; Izzo, J.G.; Hanna, A.E.; Cody, D.D.; Langley, R.R.; Tang, H.; Burdick, M.D.; Sato, M.; Minna, J.D.; et al. High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. Cancer Res. 2006, 66, 4198-4207.
25. Zhong, L.; Roybal, J.; Chaerkady, R.; Zhang, W.; Choi, K.; Alvarez, C.A.; Tran, H.; Creighton, C.J.; Yan, S.; Strieter, R.M.; et al. Identification of secreted proteins that mediate cell-cell interactions in an in vitro model of the lung cancer microenvironment. Cancer Res. 2008, 68, 7237-7245.
26. Anisowicz, A.; Messineo, M.; Lee, S.W.; Sager, R. An NF-kappa B-like transcription factor mediates IL-1/TNF-alpha induction of gro in human fibroblasts. J. Immunol. 1991, 147, 520-527.
27. Hao, Q.; Wang, L.; Tang, H. Vascular endothelial growth factor induces protein kinase D-dependent production of proinflammatory cytokines in endothelial cells. Am. J. Physiol. 2009, 296, C821-C827.
28. Koch, S.; Tugues, S.; Li, X.; Gualandi, L.; Claesson-Welsh, L. Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 2011, 437, 169-183.
29. Mao, W.-F.; Shao, M.-H.; Gao, P.-T.; Ma, J.; Li, H.-J.; Li, G.-L.; Han, B.-H.; Yuan, C.-G. The important roles of RET, VEGFR2 and the RAF/MEK/ERK pathway in cancer treatment with sorafenib. Acta Pharmacol. Sin. 2012, 33, 1311-1318.
30. Leppa, S.; Bohmann, D. Diverse functions of JNK signaling and c-Jun in stress response and apoptosis. Oncogene 1999, 18, 6158-6162.
31. Kyriakis, J.M.; Avruch, J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation. Physiol. Rev. 2001, 81, 807-869.
32. Kuhns, D.B.; Gallin, J.I. Increased cell-associated IL-8 in human exudative and A23187-treated peripheral blood neutrophils. J. Immunol. 1995, 154, 6556-6562.
33. Pellmé, S.; Mörgelin, M.; Tapper, H.; Mellqvist, U.-H.; Dahlgren, C.; Karlsson, A. Localization of human neutrophil interleukin-8 (CXCL-8) to organelle(s) distinct from the classical granules and secretory vesicles. J. Leukoc. Biol. 2006, 79, 564-573.
34. Issa, R.; Xie, S.; Khorasani, N.; Sukkar, M.; Adcock, I.M.; Lee, K.-Y.; Chung, K.F. Corticosteroid inhibition of growth-related oncogene protein-α via mitogen-activated kinase phosphatase-1 in airway smooth muscle cells. J. Immunol. 2007, 178, 7366-7375.
35. Chen, C.C.; Manning, A.M. TGF-β1, IL-10 and IL-4 differentially modulate the cytokine-induced expression of IL-6 and IL-8 in human endothelial cells. Cytokine 1996, 8, 58-65.
36. Bierie, B.; Stover, D.G.; Abel, T.W.; Chytil, A.; Gorska, A.E.; Aakre, M.; Forrester, E.; Yang, L.; Wagner, K.-U.; Moses, H.L. Transforming growth factor-β regulates mammary carcinoma cell survival and interaction with the adjacent microenvironment. Cancer Res. 2008, 68, 1809-1819.
37. Moustakas, A.; Heldin, C.-H. The regulation of TGFβ signal transduction. Development 2009, 136, 3699-3714.
38. Biernacka, A.; Dobaczewski, M.; Frangogiannis, N.G. TGF-beta signaling in fibrosis. Growth Factors 2011, 29, 196-202.
39. Derynck, R.; Zhang, Y.E. Smad-dependent and smad-independent pathways in TGF-[beta] family signalling. Nature 2003, 425, 577-584.
40. Toonkel, R.L.; Borczuk, A.C.; Powell, C.A. TGF-[beta] Signaling pathway in lung adenocarcinoma invasion. J. Thorac. Oncol. 2010, 5, 153-157.
41. Inoue, T.; Ishida, T.; Takenoyama, M.; Sugio, K.; Sugimachi, K. The relationship between the immunodetection of transforming growth factor-beta in lung adenocarcinoma and longer survival rates. Surg. Oncol. 1995, 4, 51-57.
42. Shieh, J.-M.; Huang, T.-F.; Hung, C.-F.; Chou, K.-H.; Tsai, Y.-J.; Wu, W.-B. Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells. Br. J. Pharmacol. 2010, 160, 1171-1184.
43. Chen, C.-P.; Hung, C.-F.; Lee, S.-C.; Lo, H.-M.; Wu, P.-H.; Wu, W.-B. Lycopene binding compromised PDGF-AA/-AB signaling and migration in smooth muscle cells and fibroblasts: prediction of the possible lycopene binding site within PDGF. Naunyn-Schmiedeberg's Arch. Pharmacol. 2010, 381, 401-414.